Abstract
Due to the relatively heterogeneous metastatic spread of renal cell carcinoma (RCC) through both hematogenous and lymphatogenous routes, the surgical extirpation of regional lymph nodes in the treatment of RCC has long been a controversial topic. Individual risk is dependent on multiple variables including tumor stage, grade, and histologic sub-type, in addition to many others. Controversy exists over whether lymph node dissection (LND) simply provides improved staging or whether removal of pathologic nodes offers a therapeutic advantage. Herein, we evaluate the available data regarding the use of LND in the treatment of RCC. While we believe that LND may provide an opportunity for cure in a select group of patients, there are many variables to consider when determining its applicability to an individual patient.
Similar content being viewed by others
References
Blom JH, van Poppel H, Marechal JM et al (2009) Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55(1):28–34
Blute ML, Leibovich BC, Cheville JC et al (2004) A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172(2):465–469
Vasselli JR, Yang JC, Linehan WM et al (2001) Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol 166(1):68–72
Wood DP Jr (1991) Role of lymphadenectomy in renal cell carcinoma. Urol Clin N Am 18(3):421–6
Mortensen H (1948) Transthoracic nephrectomy. J Urol 60(6):855–858
Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101(3):297–301
Van Poppel H (2011) Lymph node dissection is not obsolete in clinically node-negative renal cell carcinoma patients. Eur Urol 59(1):24–25
Assouad J, Riquet M, Foucault C et al (2006) Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology 39(1):26–32
Assouad J, Riquet M, Berna P et al (2007) Intrapulmonary lymph node metastasis and renal cell carcinoma. Eur J Cardiothorac Surg 31(1):132–134
Crispen PL, Breau RH, Allmer C et al (2011) Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol 59(1):18–23
Terrone C, Cracco C, Porpiglia F et al (2006) Reassessing the current TNM lymph node staging for renal cell carcinoma. Eur Urol 49(2):324–331
Johnsen JA, Hellsten S (1997) Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 157(2):450–453
Herrlinger A, Schrott KM, Schott G et al (1991) What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J Urol 146(5):1224–1227
Margulis V, Wood CG (2008) The role of lymph node dissection in renal cell carcinoma: the pendulum swings back. Cancer J (Sudbury, Mass) 14(5):308–314
Ferrigni RG, Novicki DE (1985) Chylous ascites complicating genitourinary oncological surgery. J Urol 134(4):774–776
Freedland SJ, Dekernion JB (2003) Role of lymphadenectomy for patients undergoing radical nephrectomy for renal cell carcinoma. Rev Urol 5(3):191–195
Pantuck AJ, Zisman A, Dorey F et al (2003) Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 169(6):2076–2083
Chapman TN, Sharma S, Zhang S et al (2008) Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. Urology 71(2):287–291
Studer UE, Scherz S, Scheidegger J et al (1990) Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144(2 Pt 1):243–245
Pantuck AJ, Zisman A, Belldegrun AS (2001) The changing natural history of renal cell carcinoma. J Urol 166(5):1611–1623
Edge SB (2010) American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. Springer, New York
Ward JF, Blute ML, Cheville JC et al (2002) The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. J Urol 168(1):56–60
Dimashkieh HH, Lohse CM, Blute ML et al (2006) Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol 176(5):1978–1982; discussion 82–83
Kwon T, Song C, Hong JH et al (2011) Reassessment of renal cell carcinoma lymph node staging: analysis of patterns of progression. Urology 77(2):373–378
Delacroix SE, Chapin BF, Chen JJ et al (2011) Can a durable disease free survival be achieved with surgical resection in patients with pathologic node positive renal cell carcinoma? J Urol 185(10) (in press)
Terrone C, Guercio S, De Luca S et al (2003) The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91(1):37–40
Whitson JM, Harris CR, Reese AC et al (2011) Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol 185(5):1615–1620
Margulis V, Tamboli P, Matin SF et al (2008) Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 112(7):1480–1488
Hutterer GC, Patard JJ, Perrotte P et al (2007) Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer 121(11):2556–2561
Thompson R (2008) Preoperative nomogram to predict positive lymph nodes during nephrectomy for renal cell carcinoma. J Urol 179(Supplement No. 4):212
Ming X, Ningshu L, Hanzhong L et al (2009) Value of frozen section analysis of enlarged lymph nodes during radical nephrectomy for renal cell carcinoma. Urology 74(2):364–368
Bex A, Vermeeren L, de Windt G et al (2010) Feasibility of sentinel node detection in renal cell carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 37(6):1117–1123
Bex A, Vermeeren L, Meinhardt W et al (2010) Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: initial experience in 20 patients. World J Urol (Epub ahead of print)
Karakiewicz PI, Trinh QD, Bhojani N et al (2007) Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 51(6):1616–1624
Peters PC, Brown GL (1980) The role of lymphadenectomy in the management of renal cell carcinoma. Urol Clin N Am 7(3):705–709
Boorjian SA, Crispen PL, Lohse CM et al (2008) Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol 180(1):99–103 (discussion)
Lughezzani G, Capitanio U, Jeldres C et al (2009) Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer 115(24):5680–5687
Pantuck AJ, Zisman A, Dorey F et al (2003) Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer 97(12):2995–3002
Conflict of interest
No author has any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Chapin, B.F., Delacroix, S.E. & Wood, C.G. The role of lymph node dissection in renal cell carcinoma. Int J Clin Oncol 16, 186–194 (2011). https://doi.org/10.1007/s10147-011-0241-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-011-0241-3